| Study of Real-world Evidence With SGLT2i (Dapagliflozin) and DPP4i (Sitagliptin) in Type 2 Diabetes Patients in Spain (NCT04149067) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2017-06-05 |
| Co-ingestion of Rice Bran Soymilk or Plain Soymilk With White Bread: Effects on the Glycaemic and Insulinaemic Response (NCT03447080) | Singapore Institute of Food and Biotechnology Innovation | 2017-06-02 |
| Effect of Motivation Text Messages on Diabetes Patients (NCT03167866) | Rambam Health Care Campus | 2017-06-01 |
| Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia (NCT03132571) | Yale University | 2017-06-01 |
| A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes (NCT03115099) | Eli Lilly and Company | 2017-05-31 |
| Professional Continuous Glucose Monitoring as an Adjuvant Educational Tool for Improving Glycemic Control in Patients With Type 2 Diabetes. (NCT04667728) | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 2017-05-30 |
| Empaglifozin in Early Diabetic Kidney Disease (NCT03173963) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-05-27 |
| A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD) (NCT03175120) | Novo Nordisk A/S | 2017-05-26 |
| A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) (NCT03172494) | Novo Nordisk A/S | 2017-05-26 |
| Glooko mHealth Advantage Study (NCT02974816) | Glooko | 2017-05-15 |
| Carnitine and Liver Mitochondria Fatty Acid Processing (NCT03193125) | Pennington Biomedical Research Center | 2017-05-15 |
| Effectiveness of Proprioceptive Training on Plantar Pressure, Balance, Posture and Gait in Individuals With Diabetes Mellitus Type 2 (NCT03390959) | Kelly Antunes e Silva Oliveira | 2017-05-10 |
| Hypoglycemic Efficacy of Greenyn Momordica Charantia Extracts in Diabetic Subjects (NCT03151837) | Chung Shan Medical University | 2017-05-10 |
| Commercial Prebiotic Supplement Study (NCT03141710) | University of Aberdeen | 2017-05-10 |
| Effectiveness of a Nurse-led Integrative Health and Wellness Programme Among Newly Diagnosed Type 2 Diabetes Patients (NCT03261895) | Chinese University of Hong Kong | 2017-05-04 |
| Perceived Stress and Negative Thoughts With Biomarkers in People With Type 2 Diabetes Mellitus and Healthy Subjects (NCT04387045) | Francisco Carlos López Marquez | 2017-05-02 |
| Use of Nutraceuticals in Clinical Practice (NCT04161859) | University of Pavia | 2017-05-01 |
| Effect of Folic Acid and Vitamin B12 Supplementation in Subjects With Type 2 Diabetes (NCT02786823) | All India Institute of Medical Sciences, Bhubaneswar | 2017-05-01 |
| The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM (NCT03174522) | Ixaka Ltd | 2017-04-25 |
| Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients (NCT04012775) | Geropharm | 2017-04-20 |
| EMPRA (EMPagliflozin and RAs in Kidney Disease) (NCT03078101) | Medical University of Vienna | 2017-04-15 |
| The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM (NCT03111238) | Ixaka Ltd | 2017-04-05 |
| Plasma Dihydroceramides Are Associated With Hepatic Steatosis in Type 1 and Type 2 Diabetes (NCT03447964) | Groupe Hospitalier Pitie-Salpetriere | 2017-04-04 |
| Effect of Whole-body Vibration on TcPO2 (NCT03957811) | Instituto Nacional de Rehabilitacion | 2017-04-04 |
| Development and Implementation of Ramadan Fasting Algorithm for Singaporeans With Type 2 Diabetes (NCT03314246) | Joyce Lee | 2017-04-03 |
| The Effect of Social Relationships on Psychological Distress and Disease Progression in Patients With Diabetes (NCT03083795) | BCDiabetes.Ca | 2017-04-01 |
| A Diabetes Improvement in Medical Therapy Versus SADJB Study (NCT03165812) | Universiti Putra Malaysia | 2017-04-01 |
| Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data (NCT03078049) | AstraZeneca | 2017-03-31 |
| A Digital Health Tool for Insulin Titration (DHIT) Individuals With Type 2 Diabetes: A Prospective Outcomes Study With a Retrospective Control Group (NCT03138447) | Amalgam Rx, Inc. | 2017-03-30 |
| Impact of an Evidence-based Electronic Decision Support System on Diabetes Care (NCT01830569) | KU Leuven | 2017-03-29 |
| A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects (NCT03061981) | Dong-A ST Co., Ltd. | 2017-03-29 |
| BEYO Project to Promote Sense of Coherence and Self-care of Elderly People With Type 2 Diabetes (NCT03237975) | Chinese University of Hong Kong | 2017-03-27 |
| mHealth for Diabetes Adherence Support (NCT02990299) | University of Illinois at Chicago | 2017-03-24 |
| In and ex Vivo Mitochondrial Function of the Heart (NCT03049228) | Maastricht University Medical Center | 2017-03-21 |
| Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus (NCT03086330) | Novo Nordisk A/S | 2017-03-15 |
| Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes (NCT03136484) | Novo Nordisk A/S | 2017-03-15 |
| A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs (NCT03078478) | Novo Nordisk A/S | 2017-03-13 |
| Impact of Therapeutic Footwear and Plantar Orthoses on Diabetic Neuropathic Foot in Quality of Life and Functionality (NCT04605900) | Universidade do Algarve | 2017-03-13 |
| A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease (NCT03060538) | Genentech, Inc. | 2017-03-05 |
| LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors. (NCT02964247) | Novo Nordisk A/S | 2017-03-03 |
| Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c (NCT03092882) | Evidation Health | 2017-03-03 |
| Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin (NCT03060980) | Intarcia Therapeutics | 2017-03-03 |
| Serum Endostatin Type 2 Diabetic Patients (NCT03404037) | Zagazig University | 2017-03-02 |
| Clinical Characteristics and Practice Patterns of Type 2 Diabetes Mellitus Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDV (NCT03092752) | Boehringer Ingelheim | 2017-03-01 |
| Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D) (NCT02879383) | Fractyl Health Inc. | 2017-03-01 |
| Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension (NCT03091920) | Cyclerion Therapeutics | 2017-02-28 |
| Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients (NCT03039569) | University of Nebraska Lincoln | 2017-02-28 |
| Shift Work, Heredity, Insulin, and Food Timing Study (NCT02997319) | Massachusetts General Hospital | 2017-02-24 |
| Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan (NCT02941367) | Sanofi | 2017-02-23 |
| Targeted Enteral Nutrient Delivery: A Prospective Randomized Study (NCT03064347) | University of Southern California | 2017-02-22 |
| Study With Dapagliflozin (NCT02971618) | AstraZeneca | 2017-02-21 |
| Raclopride-PET/MRT (NCT03637075) | University Hospital Tuebingen | 2017-02-20 |
| Diabetes In Sindhi Families In Nagpur (DISFIN) (NCT03918525) | Lata Medical Research Foundation, Nagpur | 2017-02-20 |
| Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger (NCT03207711) | University of California, San Francisco | 2017-02-17 |
| Whole Grains, Gastric Emptying and Glycemic Response (NCT03467659) | Purdue University | 2017-02-16 |
| Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan (NCT04237493) | University of Jordan | 2017-02-14 |
| Effect of Vitamins D3 and K2 in uOc and Insulin Serum Levels in Patients With Diabetes Mellitus (NCT04041492) | University of Guadalajara | 2017-02-14 |
| Resistant Starch, Gut Bacteria and Diabetes (NCT03057444) | University of Hohenheim | 2017-02-10 |
| Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin (NCT03021187) | Novo Nordisk A/S | 2017-02-02 |
| Hypoglycaemia and Cardiac Arrhythmias in Type 2 Diabetes (NCT03150030) | University Hospital, Gentofte, Copenhagen | 2017-02-01 |
| Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes (NCT03005288) | Novartis Pharmaceuticals | 2017-02-01 |
| A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese (NCT03018665) | The First Hospital of Jilin University | 2017-02-01 |
| Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans (NCT03077360) | University of Colorado, Denver | 2017-02-01 |
| Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes (NCT03037528) | University of Michigan | 2017-01-27 |
| Effect of Walking on Sand With Dietary Intervention in Overweight Type 2 Diabetes Mellitus Patients. (NCT04364685) | Majmaah University | 2017-01-25 |
| The Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus (NCT03061851) | Qingdao Zhixin Health Technology Co., Ltd. | 2017-01-25 |
| Determinants of Type 2 Diabetes Risk in Middle-aged Black South African Men and Women (NCT03408678) | University of Witwatersrand, South Africa | 2017-01-23 |
| A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes (NCT02692716) | Novo Nordisk A/S | 2017-01-17 |
| Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes (NCT03018028) | Novo Nordisk A/S | 2017-01-10 |
| Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes (NCT03015220) | Novo Nordisk A/S | 2017-01-10 |
| Systemic Metabolic Rate of Diabetic Patients Before and After Bariatric Gastric Bypass Using the Breezing® Device. (NCT05505773) | Kaiser Clinic and Hospital | 2017-01-06 |
| CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes (NCT02912455) | The Cleveland Clinic | 2017-01-05 |
| Effects of Acute High Intensity Exercise Training on Cardiac Function in Type II Diabetes (NCT02998008) | Norwegian University of Science and Technology | 2017-01-02 |
| Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes (NCT03473262) | Chungbuk National University Hospital | 2017-01-01 |
| Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes (NCT05925829) | Hayandra Peduli Foundation | 2017-01-01 |
| Effects of a Exercise Program on Health Outcomes in People With Diabetic Foot Ulcers (NCT03002155) | University of Washington | 2017-01-01 |
| Impact of CMS Reimbursement Policy Supporting Care Coordination in Louisiana (NCT03136471) | Tulane University | 2017-01-01 |
| Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery (NCT02919345) | University of Campinas, Brazil | 2017-01-01 |
| Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy (NCT05103306) | Chungbuk National University Hospital | 2017-01-01 |
| Glycation of apoA-I and Diabetic Atherogenesis (NCT05659043) | Ruijin Hospital | 2017-01-01 |
| Risk Factors for Type 2 Diabetes Mellitus With Cognitive Impairment: a Cohort Study (NCT05728567) | Peking University | 2017-01-01 |
| CArdioMetabolism and Atherosclerotic PlaqUe progreSsion (NCT05117424) | Ruijin Hospital | 2017-01-01 |
| Treatment Adherence Intervention in Patients With Type 2 Diabetes and Comorbid Depression (NCT04097483) | Alicia Monreal Bartolomé | 2017-01-01 |
| GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes. (NCT06017544) | University of Campania Luigi Vanvitelli | 2017-01-01 |
| Evaluation of Health and Lifestyle Tool (NCT04691973) | Region Skane | 2017-01-01 |
| Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice (NCT02989649) | Takeda | 2016-12-22 |
| Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration (NCT02911792) | The University of Texas Health Science Center at San Antonio | 2016-12-20 |
| Evaluation of Non - Surgical Periodontal Therapy in Diabetic Patients. (NCT03764410) | Universidade Metropolitana de Santos | 2016-12-20 |
| A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes (NCT02942914) | Eli Lilly and Company | 2016-12-20 |
| The Effects of an Intensive Lifestyle Intervention for Type 2 Diabetes on Disability Insurance (NCT04515745) | University of Minnesota | 2016-12-19 |
| The Effects of an Intensive Lifestyle Intervention on Employment, Earnings, and Retirement (NCT04563598) | University of Minnesota | 2016-12-19 |
| Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction. (NCT02919059) | IInstituto Gallego de Medicina Vascular | 2016-12-13 |
| Effects of Low Intensity Therapeutic Ultrasound on Endothelial Function (NCT02872922) | Universidade Federal de Santa Maria | 2016-12-10 |
| Chronotype of Patients With Diabetes and Effect on Glycaemic Control (NCT02973412) | University of Leicester | 2016-12-07 |
| SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation. (NCT02798744) | University of Leicester | 2016-12-01 |
| Empa PASS on Urinary Tract Malignancies (NCT03464045) | Boehringer Ingelheim | 2016-11-16 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes (NCT02964104) | Novo Nordisk A/S | 2016-11-15 |
| Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect (NCT03806920) | German Institute of Human Nutrition | 2016-11-05 |
| HbA1c Variability in Type II Diabetes (NCT02879409) | Weill Cornell Medical College in Qatar | 2016-11-01 |
| The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes (NCT02890745) | Henrik Enghusen Poulsen | 2016-11-01 |